Derangement of immune responses by myeloid suppressor cells (Q35573513)

8 August 2017

1 reference

title

Derangement of immune responses by myeloid suppressor cells (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

27 March 2024

Ilaria Marigo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14593498

27 March 2024

Sara Cingarlini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14593498

27 March 2024

Paola Zanovello

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14593498

27 March 2024

Paolo Serafini

1 reference

8 August 2017

Carmela De Santo

1 reference

8 August 2017

Luigi Dolcetti

1 reference

8 August 2017

Giovanna Gallina

1 reference

8 August 2017

Vincenzo Bronte

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14593498

27 March 2024

publication date

30 October 2003

1 reference

full work available at URL

8 August 2017

https://link.springer.com/content/pdf/10.1007/s00262-003-0443-2.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

https://link.springer.com/article/10.1007/s00262-003-0443-2/fulltext.html

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

http://link.springer.com/content/pdf/10.1007/s00262-003-0443-2

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Cancer Immunology, Immunotherapy

27 March 2024

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

64-72

1 reference

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Immunosuppression induced by attenuated Salmonella: Effect of LPS responsiveness on development of suppression

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Role of ornithine as a proline precursor in healing wounds

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1α

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillanc

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Strategies for designing and optimizing new generation vaccines

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Classical and slow-binding inhibitors of human type II arginase

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Alternative activation of macrophages

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Tumor-induced immune dysfunction

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Regulation of adaptive immunity by natural killer cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Immature myeloid cells and cancer-associated immune suppression

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Flow cytometric identification of murine neutrophils and monocytes.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Markers of mouse macrophage development detected by monoclonal antibodies

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Progress in Clinical and Biological Research

27 March 2024

288

235

Maier

1989

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factor

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Membrane molecules as differentiation antigens of murine macrophages.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

M-1/M-2 macrophages and the Th1/Th2 paradigm

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Melanoma vaccines: the paradox of T cell activation without clinical response

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Effects of L-arginine on the proliferation of T lymphocyte subpopulations

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Arginase release from red blood cells: possible link in transfusion induced immune suppression?

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Regulation of T cell receptor CD3zeta chain expression by L-arginine

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Resection of solid tumors reverses T cell defects and restores protective immunity

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

NKT cells and tumor immunity—a double-edged sword

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Natural Suppressor (NS) Cells, Neonatal Tolerance, and Total Lymphoid Irradiation: Exploring Obscure Relationships

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

27 March 2024

205

Suh

1997

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Clinical significance of the determination of angiogenic factors

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Blocking NO synthesis: how, where and why?

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Uses of granulocyte-macrophage colony-stimulating factor in vaccine development

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Arginine metabolism: nitric oxide and beyond

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0443-2

27 March 2024

Identifiers

1 reference

release_vfmgfu2skbe5pikytuyyzcvks4

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vfmgfu2skbe5pikytuyyzcvks4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference